Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-11 Purchase | 2024-09-12 06:32 am | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 1,250 | $3.68 | $4,600 | 1,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-03 3:16 pm | 2025-07-01 2034-07-01 | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 1,778 | $0 | 1,778 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 5:59 pm | N/A 2034-05-23 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 285,000 | $0 | 285,000 (Direct) | View |
Ownership | 2024-04-04 5:49 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 0 | $0 | 981,519 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 4:45 pm | N/A 2033-09-29 | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 8,000 | $0 | 8,000 (Direct) | View |